Cardiac magnetic resonance and galectin-3 level as predictors of prognostic outcomes for non-ischemic cardiomyopathy patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cardiac magnetic resonance and galectin-3 level as predictors of prognostic outcomes for non-ischemic cardiomyopathy patients

Published:2016-08-26 Issue:12 Volume:32 Page:1725-1733
ISSN:1569-5794
Container-title:The International Journal of Cardiovascular Imaging
language:en
Short-container-title:Int J Cardiovasc Imaging

Author:

Hu Da-Jun,Xu Jing,Du Wei,Zhang Jian-Xin,Zhong Min,Zhou Ya-Nan

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging

Link

http://link.springer.com/content/pdf/10.1007/s10554-016-0958-1.pdf

Reference47 articles.

1. Smith N, Steeds R, Masani N et al (2015) A systematic approach to echocardiography in hypertrophic cardiomyopathy: a guideline protocol from the british society of echocardiography. Echo Res Pract 2:G1–G7. doi: 10.1530/ERP-14-0115

2. Khan R, Massel D, Stirrat J et al (2013) Myocardial fibrosis and quality of life in patients with non-ischemic cardiomyopathy: a cardiovascular magnetic resonance imaging study. Int J Cardiovasc Imaging 29:395–404. doi: 10.1007/s10554-012-0107-4

3. Maron BJ, Towbin JA, Thiene G et al (2006) Contemporary definitions and classification of the cardiomyopathies: an american heart association scientific statement from the council on clinical cardiology, heart failure and transplantation committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and council on epidemiology and prevention. Circulation 113:1807–1816. doi: 10.1161/CIRCULATIONAHA.106.174287

4. Basso C, Thiene G, Corrado D et al (2000) Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia. Hum Pathol 31:988–998. doi: 10.1053/hupa.2000.16659

5. Mann DL, Bristow MR (2005) Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation 111:2837–2849. doi: 10.1161/CIRCULATIONAHA.104.500546

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognosis value of galectin-3 in patients with dilated cardiomyopathy: a meta-analysis;PeerJ;2024-04-23

2. Hypertrophic Cardiomyopathy–Advances in Imaging and Diagnostic Strategies;Veterinary Clinics of North America: Small Animal Practice;2023-11

3. Link between fibrosis-specific biomarkers and interstitial fibrosis in hypertrophic cardiomyopathy;Kardiologia Polska;2023-08-26

4. Impact of late gadolinium-enhanced cardiac MRI on arrhythmic and mortality outcomes in nonischemic dilated cardiomyopathy: updated systematic review and meta-analysis;Scientific Reports;2023-08-23

5. Galectin-3 as a novel biomarker in cats with hypertrophic cardiomyopathy;Journal of Veterinary Cardiology;2023-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3